On November 13, 2026, five insiders at PepGen Inc. (PEPG) executed significant share purchases, collectively acquiring approximately $215.62 million worth of stock. The transactions, each valued at $43.12 million for 8,625,000 shares at a price of $5.00 per share, were made by Capital Nexus Fund II, L.P., Rajeev M. Shah (Director, 10% Owner), Peter Kolchinsky (Director, 10% Owner), Capital Management, L.P., and Capital Healthcare Fund, L.P.
This coordinated buying activity from multiple company insiders is often interpreted as a strong bullish signal by market observers. Rajeev M. Shah and Peter Kolchinsky are both directors and 10% owners of PepGen.
PepGen Inc. operates in the biotechnology sector, focusing on developing novel therapies for genetically defined diseases. The substantial investment from key individuals within the company may indicate a heightened conviction in PepGen's future prospects and development pipeline.